IL-1β and IL-18 have a central role in the cardiomyocyte apoptosis and fibroblast activation of DCM, which is thought to be the initiator of the structural disorder (Santiago et al., 2014; Somanna et al., 2015). This evidence concerns the gene IL1B and familial dilated cardiomyopathy.